The company has launched paricalcitol capsules in the US market in the strengths of 1 mcg, 2 mcg and 4 mcg on June 24 after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's said in a statement.
Drug firm Dr Reddy's Laboratories has launched generic Paricalcitol capsules used for treating secondary hyperparathyroidism associated with chronic kidney disease in the American market, following approval by the US health regulator.
The company has launched paricalcitol capsules in the US market in the strengths of 1 mcg, 2 mcg and 4 mcg on June 24 after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's said in a statement.
The product is generic version of AbbVie Inc's Zemplar capsules, it added.
"The Zemplar brand and generic had US sales of approximately USD 109.6 million MAT for the most recent twelve months ending in March 2014 according to IMS Health," Dr Reddy's said.
The company's capsules in three strengths of 1 mcg, 2 mcg and 4 mcg are available in bottle counts of 30, it added.
Shares of Dr Reddy's Laboratories were trading 0.23 percent up at Rs 2,466.40 per scrip on the BSE in morning trade today.
Dr Reddys Labs stock price
On June 25, 2014, Dr Reddys Laboratories closed at Rs 2479.35, up Rs 18.50, or 0.75 percent. The 52-week high of the share was Rs 2939.80 and the 52-week low was Rs 2025.00.
The company's trailing 12-month (TTM) EPS was at Rs 113.51 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 21.84. The latest book value of the company is Rs 570.62 per share. At current value, the price-to-book value of the company is 4.35.
Anda sedang membaca artikel tentang
Dr Reddy's launches generic Paricalcitol capsules in US mkt
Dengan url
http://gayafashionshow.blogspot.com/2014/06/dr-reddys-launches-generic-paricalcitol.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Dr Reddy's launches generic Paricalcitol capsules in US mkt
namun jangan lupa untuk meletakkan link
Dr Reddy's launches generic Paricalcitol capsules in US mkt
sebagai sumbernya
0 komentar:
Posting Komentar